Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression

Major depressive disorder has become a prominent cause of disability, as lifetime prevalence has increased to ~15% in the Western world. Pharmacological effects of serotonin (5-hydroxytryptamine, 5-HT) are mediated through 5-hydroxytryptamine receptor (5-HTR) binding. Serotonin regulation of amygdal...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Pharmacol
Autori principali: Ochi, Taichi, Vyalova, Natalya M., Losenkov, Innokentiy S., Paderina, Diana Z., Pozhidaev, Ivan V., Loonen, Anton J. M., Simutkin, German G., Bokhan, Nikolay A., Ivanova, Svetlana A., Wilffert, Bob
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2019
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6951408/
https://ncbi.nlm.nih.gov/pubmed/31956308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01462
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi